Adenosquamous Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Adenosquamous Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-14Clinical Trial Update: S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This Phase 2 clinical trial (S0536) evaluated the combination of cetuximab, paclitaxel, carboplatin, and bevacizumab in patients with advanc…
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with docetaxel plus cetuximab or docetaxel plus bortezomib in patients with Stage IIIB or Stage…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding AE-941 to combination chemotherapy and radiation improves outcomes for patients with stage III non…